WO2001093837A3 - Protein powder for pulmonary delivery - Google Patents
Protein powder for pulmonary delivery Download PDFInfo
- Publication number
- WO2001093837A3 WO2001093837A3 PCT/US2001/016472 US0116472W WO0193837A3 WO 2001093837 A3 WO2001093837 A3 WO 2001093837A3 US 0116472 W US0116472 W US 0116472W WO 0193837 A3 WO0193837 A3 WO 0193837A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pulmonary delivery
- protein powder
- particles
- surfactant
- coated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001264789A AU2001264789A1 (en) | 2000-06-08 | 2001-05-31 | Protein powder for pulmonary delivery |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21042300P | 2000-06-08 | 2000-06-08 | |
US60/210,423 | 2000-06-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001093837A2 WO2001093837A2 (en) | 2001-12-13 |
WO2001093837A3 true WO2001093837A3 (en) | 2002-05-02 |
Family
ID=22782843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/016472 WO2001093837A2 (en) | 2000-06-08 | 2001-05-31 | Protein powder for pulmonary delivery |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001264789A1 (en) |
WO (1) | WO2001093837A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9364519B2 (en) | 2011-09-01 | 2016-06-14 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
US9408893B2 (en) | 2011-08-29 | 2016-08-09 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for use in glycemic control in diabetes type 2 patients |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1797902A3 (en) * | 2000-12-29 | 2007-10-03 | Advanced Inhalation Research, Inc. | Particles for inhalation having sustained release properties |
DE10114178A1 (en) | 2001-03-23 | 2002-10-10 | Aventis Pharma Gmbh | Zinc-free and low-zinc insulin preparations with improved stability |
US7625865B2 (en) | 2004-03-26 | 2009-12-01 | Universita Degli Studi Di Parma | Insulin highly respirable microparticles |
US7772182B2 (en) | 2004-08-05 | 2010-08-10 | Alza Corporation | Stable suspension formulations of erythropoietin receptor agonists |
WO2008130220A1 (en) | 2007-04-20 | 2008-10-30 | N.V. Nutricia | Process for dispersing amino acids |
WO2009020434A1 (en) * | 2007-08-07 | 2009-02-12 | Nanomaterials Technology Pte Ltd | A process for making micro-sized protein particles |
BR122013025625B1 (en) | 2008-10-17 | 2021-08-03 | Sanofi-Aventis Deutschland Gmbh | PHARMACEUTICAL COMPOSITION, ITS USE AND METHOD OF PREPARATION OF THE SAME, KIT AND DEVICE |
US20100183876A1 (en) * | 2008-12-23 | 2010-07-22 | Hell Andre | Process for the Preparation of a Peptide Powder Form |
DK2498802T3 (en) | 2009-11-13 | 2015-04-13 | Sanofi Aventis Deutschland | Pharmaceutical composition comprising a GLP-1 agonist, insulin and a methionine |
MY159565A (en) | 2009-11-13 | 2017-01-13 | Sanofi Aventis Deutschland | Pharmaceutical composition comprising a glp-1 agonist and methionine |
HUE031181T2 (en) | 2010-08-30 | 2017-06-28 | Sanofi Aventis Deutschland | Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2 |
US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
JP6058646B2 (en) | 2011-06-15 | 2017-01-11 | ノヴォ ノルディスク アー/エス | Multi-substituted insulin |
AR099569A1 (en) | 2014-02-28 | 2016-08-03 | Novo Nordisk As | INSULIN DERIVATIVES AND THE MEDICAL USES OF THESE |
CN107106641B (en) | 2014-10-31 | 2021-12-21 | 葛兰素史密斯克莱知识产权发展有限公司 | Powder formulation |
CN107206058A (en) | 2014-12-12 | 2017-09-26 | 赛诺菲-安万特德国有限公司 | Insulin glargine/lixisenatide fixed ratio preparaton |
TWI748945B (en) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | Treatment type 2 diabetes mellitus patients |
TW201705975A (en) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | Treatment of type 2 diabetes mellitus patients |
CA3048150A1 (en) * | 2016-12-22 | 2018-06-28 | Kamada Ltd. | Dry powder formulations of alpha-1 antitrypsin |
CN113194929B (en) | 2018-12-21 | 2022-12-09 | 诺和诺德股份有限公司 | Spray drying process of GLP-1 peptide |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0634166A1 (en) * | 1993-07-15 | 1995-01-18 | Hoechst Aktiengesellschaft | Drug compositions containing coated, poorly watersoluble drugs for use in pharmaceutical inhalation forms and method to produce them |
WO1996009814A1 (en) * | 1994-09-29 | 1996-04-04 | Andaris Limited | Spray-dried microparticles as therapeutic vehicles |
US5985309A (en) * | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
WO2000012116A1 (en) * | 1998-08-28 | 2000-03-09 | Eli Lilly And Company | Method for administering insulinotropic peptides |
WO2000041682A1 (en) * | 1999-01-18 | 2000-07-20 | Lg Chemical Limited | Lipophilic microparticles containing a protein drug or antigen and formulation comprising same |
-
2001
- 2001-05-31 WO PCT/US2001/016472 patent/WO2001093837A2/en active Application Filing
- 2001-05-31 AU AU2001264789A patent/AU2001264789A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0634166A1 (en) * | 1993-07-15 | 1995-01-18 | Hoechst Aktiengesellschaft | Drug compositions containing coated, poorly watersoluble drugs for use in pharmaceutical inhalation forms and method to produce them |
WO1996009814A1 (en) * | 1994-09-29 | 1996-04-04 | Andaris Limited | Spray-dried microparticles as therapeutic vehicles |
US5985309A (en) * | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
WO2000012116A1 (en) * | 1998-08-28 | 2000-03-09 | Eli Lilly And Company | Method for administering insulinotropic peptides |
WO2000041682A1 (en) * | 1999-01-18 | 2000-07-20 | Lg Chemical Limited | Lipophilic microparticles containing a protein drug or antigen and formulation comprising same |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9408893B2 (en) | 2011-08-29 | 2016-08-09 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for use in glycemic control in diabetes type 2 patients |
US9364519B2 (en) | 2011-09-01 | 2016-06-14 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
Also Published As
Publication number | Publication date |
---|---|
AU2001264789A1 (en) | 2001-12-17 |
WO2001093837A2 (en) | 2001-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001093837A3 (en) | Protein powder for pulmonary delivery | |
WO2001005429A3 (en) | Powder particles with smooth surface for use in inhalation therapy | |
HK1201447A1 (en) | A dry powder formulation and method of making the same and use of the formulation in a dry powder inhaler | |
HUP0300593A3 (en) | Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets | |
WO2005025506A3 (en) | Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation | |
WO2002043702A3 (en) | Pharmaceutical compositions for inhalation | |
CA2304819A1 (en) | Perforated microparticles and methods of use | |
DK1294421T3 (en) | Dry powder inhaler | |
SI1402913T1 (en) | Dry powder inhalation system for transpulmonary administration, method of manufacturing a dry powdered preparation, and use of a freeze dried composition | |
WO2002080884A3 (en) | Powder inhaler formulations | |
EE04414B1 (en) | Tiotropium inhalation powder, method for its preparation and its use in the manufacture of a medicament | |
AU9043201A (en) | Continuous dry powder inhaler | |
WO2005025536A3 (en) | Dry powder composition comprising co-jet milled particles for pulmonary inhalation | |
AUPR894201A0 (en) | Respiratory delivery for gene therapy and lentiviral delivery particle | |
EG23340A (en) | Dry powder inhaler. | |
WO2001039745A3 (en) | Aerosol composition comprising formoterol | |
WO2002054868A3 (en) | Pulmonary delivery of polyene antifungal agents | |
AU2001279544A1 (en) | Inhalator and pertaining atomizer | |
IL162183A0 (en) | Polymer-lipid delivery vehicles and methods for the preparation thereof | |
CA2322045A1 (en) | Aerosolized active agent delivery | |
WO2004017918A3 (en) | Method of preparing dry powder inhalation compositions | |
WO2005025535A3 (en) | Methods for preparing pharmaceutical compositions | |
HUP0103837A3 (en) | Dry powder active agent pulmonary delivery and process for its preparation | |
PL387118A1 (en) | Inhalation capsules comprising tiotropium and the use thereof | |
WO2007028512A3 (en) | Magnetic-field controlled active substance transfer for aerosol therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |